Hang Sheng Zhou
Vorstandsvorsitzender bei Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Profil
Hang Sheng Zhou is currently the Chief Executive Officer at Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Prior to this, he worked as the Chief Financial Officer & Managing Director at Humanwell Healthcare (Group) Co., Ltd.
Dr. Zhou also served as an Independent Non-Executive Director at AbelZeta Pharma, Inc. from 2016 to 2021.
He received his undergraduate degree from Wuhan University and his doctorate from Beijing Institute of Technology.
Aktive Positionen von Hang Sheng Zhou
| Unternehmen | Position | Beginn |
|---|---|---|
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
 Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. Financial ConglomeratesFinance Part of Wuhan Dangdai Technology Industry Group Co. Ltd., Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. operates as an investment holding company. The company is based in Wuhan, China. The CEO of the Chinese company is Hang Sheng Zhou. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Hang Sheng Zhou
| Unternehmen | Position | Ende |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Direktor/Vorstandsmitglied | 19.02.2021 |
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Vorstandsvorsitzender | - |
Ausbildung von Hang Sheng Zhou
| Wuhan University | Undergraduate Degree |
| Beijing Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AbelZeta Pharma, Inc.
 AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. Financial ConglomeratesFinance Part of Wuhan Dangdai Technology Industry Group Co. Ltd., Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. operates as an investment holding company. The company is based in Wuhan, China. The CEO of the Chinese company is Hang Sheng Zhou. | Finance |
